Výsledky vyhledávání - "M. A. Koike Folgueira"

Breast cancer gene expression profile in young women who are noncarriers of BRCA1/2 mutations with and without familial history

Autor: Patrícia Locosque Ramos, Dirce Maria Carraro, Maria Lucia Hirata Katayama, M. A. Koike Folgueira, M. W. Achatz, B. C. Lisboa, Helena Brentani, Maria Mitzi Brentani, Carlos Alberto Moreira-Filho

Publikováno v: Journal of Clinical Oncology. 28:1538-1538

1538 Background: Breast cancer (BC) in young women is associated with worse prognosis and positive family history of breast and/or ovarian cancer with risk gene mutations, particularly BRCA gene germline mutations. However mutations in the BRCA1/2 ge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::daedd96072eca613ed91f1ba6b1970d5
https://doi.org/10.1200/jco.2010.28.15_suppl.1538

Zobrazit plný text záznamu

Differential gene profiling of malignant cells and fibroblasts from the primary and metastatic sites from breast cancer patients upon stroma-epithelial cell interaction

Autor: Maria Lucia Hirata Katayama, T. T Benvenuti, E. C. Lyra, R. P. C. Santos, Helena Brentani, Suzana Terumi Honda, Maria Mitzi Brentani, M. A. Koike Folgueira, Dirce Maria Carraro, Patricia Bortman Rozenchan

Publikováno v: Journal of Clinical Oncology. 24:10570-10570

10570 Background: In breast cancer (BC), stromal-epithelial cell interactions may influence tumor development in the primary tumor (PT) and metastatic sites, which may be reflected by a differential phenotype of malignant cells and fibroblasts (Fb).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e428f203ed91da52dda591648706d9a
https://doi.org/10.1200/jco.2006.24.18_suppl.10570

Zobrazit plný text záznamu

Expression profile of residual breast cancer after primary chemotherapy based on doxorubicin

Autor: M. L.H. Katayama, Dirce Maria Carraro, Maria Mitzi Brentani, D. F. Padrao, M. A. Koike Folgueira, Louise Danielle de Carvalho Mota, E. M. Barbosa, C. T. Oliveira, M. Mourão Netto, Helena Brentani

Publikováno v: Journal of Clinical Oncology. 23:639-639

639 Background: Expression profile of the remaining malignant cells in breast cancer after the last cycle of primary chemotherapy (PCT) based on doxorubicin (AC) might help to identify a resistant ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::625334ae477e7b503a007031407dd0fd
https://doi.org/10.1200/jco.2005.23.16_suppl.639

Zobrazit plný text záznamu

Genes differentially expressed in breast cancer (BC) samples as compared to normal breast tissue from women without cancer

Autor: Dirce Maria Carraro, Helena Brentani, M. A. Koike Folgueira, Maria Mitzi Brentani, Luiz Paulo Camargo, M. Mourão Netto, C. T. Oliveira, J. R. F. Caldeira, Fernando Augusto Soares, E. M. Barbosa

Publikováno v: Journal of Clinical Oncology. 22:9593-9593

9593 Background: We have determined the gene profile correlated to doxorubicin resistance in 38 BC patients (pt) treated with primary chemotherapy and 37 genes were differentially expressed in tumors according to response. Among the genes more expres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f9a973505d2ef8f8ec361947cf906a7
https://doi.org/10.1200/jco.2004.22.90140.9593

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání